Mevacor


Also found in: Dictionary, Medical, Wikipedia.
Related to Mevacor: lovastatin
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for Mevacor

an oral drug (trade name Mevacor) to reduce blood cholesterol levels

References in periodicals archive ?
An analysis of data from the large-scale Women's Health Initiative showed that while hydrophilic statins such as Pravachol, Lipitor, and Crestor did not confer any reduction in breast cancer risk, the hydrophobic statins such as Zocor, Mevacor, and Lescol were associated with an 18% reduction in the relative risk of breast cancer.
Last January a Food and Drug Administration (FDA) advisory panel considered a proposal to put Mevacor within easier reach.
But in 2001, the Food and Drug Administration pursuaded a federal district court to ban Cholestin because the supplement contained the same active ingredients found in the prescription statin drug Mevacor.
The Thousand Oaks-based company, one of the nation's biggest health insurers, wants to reduce the cost of pricey prescriptions by subsidizing generic versions of popular medications like Prozac and Mevacor over their brand-name counterparts.
Lipitor, Zocor, Mevacor, and Pravachol are statins that block your body's production of cholesterol, raise HDL, and lower LDL.
There is also evidence for the cholesterol-lowering drugs called statins (Lipitor, Lescol, Mevacor, Pravachol and Zocor) that, when started in middle to later middle-age years, they reduce the risk of dementia, type 2 diabetes and osteoporosis.
Recently the Federal Drug Administration (FDA) approved the popular cholesterol lowering drug Mevacor (generic name lovastatin) for use in adolescents.
3 new generics Three prescription drugs that will have generic equivalents between now and December 2002: Name brand Generic Date of availability Prilosec Omeprazole October 2001 (anti-ulcer) Mevacor Lovastatin December 2001 (high cholesterol) Claritin Loratidine December 2002 (antihistamine)
It didn't take long for Merck, the pharmaceutical giant, to figure, out that Pharmanex was essentially selling a natural version of its prescription drug Mevacor.
These products vary in the conditions they treat (Humulin, diabetes; Mevacor, hyperlipidemia; Dilantin, epileptic seizures; Zantac, heartburn and acute gastrointestinal ulcers), whether they are used to treat chronic or acute conditions (Dilantin and Humulin relatively more chronic), and by their sales volume (Zantac and Mevacor top ten in 1994, Humulin and Dilantin lower in the list).
His message alleged that Merck is overcharging consumers for cholesterol-reducing, and often life-saving drugs, Mevacor and Zocor.
Thus, Captopril and Mevacor, two successful drugs to treat hypertension and high cholesterol respectively, propelled Squibb and Merck into successful world class pharmaceutical companies.
The implications are far-reaching for consumers' health, healthcare providers' costs, and pharmaceutical companies' revenues in the $25 billion Statins market, including Pfizer's Lipitor, Merck's Mevacor and generics.
These supplements contain substances known as monacolins, including monacolin K (lovastatin), the primary ingredient in the statin drug Mevacor.